Technology | Patient Positioning Radiation Therapy | October 19, 2015

Orfit Announces CE, FDA Clearance for Proton Therapy Immobilization System

HP Pro Solution designed for high-precision immobilization, patient comfort in brain, head and neck treatments

Orfit Industries, HP Pro Solution, proton therapy immobilization system, ASTRO 2015, CE Mark, FDA clearance

Image courtesy of Orfit Industries

October 19, 2015 — Orfit Industries introduced and demonstrated its HP Pro Solution, an innovative, comprehensive and versatile immobilization system for proton therapy, at the American Society for Radiation Oncology (ASTRO) 57th annual meeting. The technology, designed for brain, head and neck treatments, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

When used with Orfit’s ultra-thin and stable Nanor immobilization masks, based on nanotechnology, HP Pro offers a unique combination of high-precision immobilization and patient comfort.

The British Royal Infirmary in Bristol, United Kingdom, has recently introduced a new gamma knife treatment using the Orfit radiotherapy mask. The treatment has been welcomed by specialists as a non-invasive, potential life-saver, helping to kill off unwanted growths of brain tumors with one millimeter precision, without harming healthy brain tissue.

The HP Pro hardware is designed for use in both proton and photon therapy. The products are homogenous, low density, lightweight and available in a range of configurations including overlays, extensions and a combination overlay/extension in one product. A full range of accessories, including patient-customized head rests, is available.

For more information: www.orfit.com

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing  synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of  the anatomy.

A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of the anatomy.

Feature | Radiation Oncology | May 29, 2019 | By Jeff Zagoudis
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at